Lindus Health Funding: $77M Raised, Series B (2024)
Lindus Health is a Healthtech company based in San Francisco, CA. It has raised $77M in total funding. Latest round: Series B.
Lindus Health funding overview
Lindus Health is a Healthtech company based in San Francisco, CA. Lindus Health has raised $77M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in November 2024. The round record for Lindus Health runs through 2024; nothing later has been disclosed. Investors on record include Seedcamp, Hambro Perks, Firstminute Capital, Amino Collective, Peter Thiel, Creandum and 2 others. 8 distinct backers are named across the disclosed rounds.
Lindus Health at a glance
Total raised
$77M
Latest round
Series B
Latest round date
November 2024
Industry
Healthtech
Headquarters
San Francisco, CA
Notable investors
Seedcamp, Hambro Perks, Firstminute Capital, Amino Collective, Peter Thiel, Creandum, Page One Ventures, Balderton Capital
Frequently asked about Lindus Health funding
How much has Lindus Health raised?
Lindus Health has raised $77M in total disclosed funding across the rounds on record.
Who has invested in Lindus Health?
Seedcamp, Hambro Perks, Firstminute Capital, Amino Collective, Peter Thiel, Creandum are named among the investors backing Lindus Health.
What was the latest Lindus Health funding round?
The most recent disclosed round is a Series B, announced in November 2024.
Where is Lindus Health based?
Lindus Health is based in San Francisco, CA.
What sector does Lindus Health operate in?
Lindus Health is tracked under Healthtech from San Francisco, CA, with $77M in disclosed funding.
When did Lindus Health last raise?
The last disclosed Lindus Health round closed in November 2024 at Series B.
Round data for Lindus Health is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Healthtech companies in San Francisco and backer lists below.